Clinical Trials Directory

Trials / Completed

CompletedNCT00266682

Clinical Investigation of the SelectSecure Pacing Lead

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
365 (planned)
Sponsor
Medtronic Cardiac Rhythm and Heart Failure · Industry
Sex
All
Age
0 Years
Healthy volunteers
Not accepted

Summary

People who have a slow heart beat, or whose heart does not beat on its own, may be in need of an electronic device called a pacemaker. A pacemaker is implanted surgically just under the skin in the upper chest area. This device helps the heart beat at a regular rhythm by sending electrical signals (pacing) directly to the heart tissue through flexible wires called leads. The purpose of this study is to demonstrate that the SelectSecure (Model 3830) lead is safe and effective for both sensing the heart's natural rhythm and pacing the heart when it does not beat on its own. This lead will be studied in both the right atrium and right ventricle. A previously market approved Medtronic lead model will serve as a comparison to prove the safety and effectiveness of the SelectSecure Model.

Conditions

Interventions

TypeNameDescription
DEVICEPacing Lead

Timeline

Start date
2002-08-01
Completion
2005-08-01
First posted
2005-12-19
Last updated
2006-10-13

Locations

31 sites across 3 countries: United States, Australia, Canada

Source: ClinicalTrials.gov record NCT00266682. Inclusion in this directory is not an endorsement.